Leonhard Mullauer

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications

Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma.

Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma.

Journal: Journal of experimental & clinical cancer research : CR
Published: January 28, 2026

Tumor-suppressive role of miR-216b impacts cell cycle regulation in high-grade glioma.

Tumor-suppressive role of miR-216b impacts cell cycle regulation in high-grade glioma.

Journal: Acta neuropathologica communications
Published: September 29, 2025

Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumors.

Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumors.

Journal: BMC cancer
Published: August 28, 2025

Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Randomized Clinical Trial.

Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Randomized Clinical Trial.

Journal: JAMA network open
Published: August 22, 2025

Therapeutic Effects of Lurbinectedin in PARP Inhibitor-Resistant High-Grade Serous Ovarian Cancer Using Patient-Derived Cell Lines and Organoid Models.

Therapeutic Effects of Lurbinectedin in PARP Inhibitor-Resistant High-Grade Serous Ovarian Cancer Using Patient-Derived Cell Lines and Organoid Models.

Journal: International journal of molecular sciences
Published: August 07, 2025

NTRK1 Gene Fusions Are Frequent in Juvenile Xanthogranuloma.

NTRK1 Gene Fusions Are Frequent in Juvenile Xanthogranuloma.

Journal: The American journal of surgical pathology
Published: April 16, 2025

ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer.

ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer.

Journal: Cancers
Published: December 14, 2024

Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial.

Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial.

Journal: MedComm
Published: December 13, 2024

Density and entropy of immune cells within the tumor microenvironment of primary tumors and matched brain metastases.

Density and entropy of immune cells within the tumor microenvironment of primary tumors and matched brain metastases.

Journal: Acta neuropathologica communications
Published: August 29, 2024

The atypical KRASQ22K mutation directs TGF-β response towards partial epithelial-to-mesenchymal transition in patient-derived colorectal cancer tumoroids.

The atypical KRASQ22K mutation directs TGF-β response towards partial epithelial-to-mesenchymal transition in patient-derived colorectal cancer tumoroids.

Journal: Molecular oncology
Published: August 08, 2024

Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.

Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.

Journal: Cancer cell
Published: July 30, 2024

Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype.

Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 20, 2024
Showing 1-12 of 147

Last Updated: 09/26/2026